AdetokunboOluwasanjoMD
Oncology • North Wales, PAMedical Director - Early Development, Oncology The Janssen Pharmaceutical Companies of Johnson&Johnson
Dr. Oluwasanjo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 McKean Rd
Spring House
North Wales, PA 19477
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2016 - 2019
Tower HealthResidency, Internal Medicine, 2010 - 2013
University of IbadanClass of 2005
Certifications & Licensure
TX State Medical License 2019 - 2025
PA State Medical License 2013 - 2024
FL State Medical License 2019 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 17 citationsPeripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).Adetokunbo Folashade Oluwasanjo, Saritha Kartan, William T. Johnson, Onder Alpdogan, Alejandro A. Gru
Cancer Treatment and Research. 2019-01-01 - 11 citationsFactors Supporting and Inhibiting Adherence to HIV Medication Regimen in Women: A Qualitative Analysis of Patient Interviews.Oluwakemi Y Fagbami, Adetokunbo Oluwasanjo, Carrie Fitzpatrick, Rebecca Fairchild, Ann Shin
The Open AIDS Journal. 2015-05-15 - 6 citationsRasburicase‐induced methaemoglobinaemia and G6PD deficiency in an unusual suspectAdetokunbo Oluwasanjo, Olatunji B. Alese, Sharon Swierczynski, Daniel Forman
British Journal of Haematology. 2015-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
